Our results showed not only that PCSK9 increases according to the complications associated with T2DM (e.g., previous MACE), but also that PCSK9 has the ability to predict the early onset of MACE, although in a sex-specific manner (only in women). The gene discussed is PCSK9; the disease is type 2 diabetes mellitus.